Page last updated: 2024-08-05 11:18:02
pyridoquinoline
null
ChEBI ID: 38921
Members (4)
Member | Definition | Role |
---|---|---|
flumequine | A member of the class of pyridoquinolines that is 1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline carrying additional carboxy, methyl and fluoro substituents at positions 2, 5 and 9 respectively. | 9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid |
nadifloxacin | nadifloxacin | |
torin 1 | A member of the class of pyridoquinolines that is 9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2-one bearing an additional 4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl substituent at position 1. It is a potent inhibitor of mTOR and exhibits anti-cancer properties. | torin 1 |
torin 2 | A member of the class of pyridoquinolines that is benzo[h][1,6]naphthyridin-2-one carrying additional 3-(trifluoromethyl)phenyl and 6-aminopyridin-3-yl substituents at positions 1 and 9 respectively. It is a potent inhibitor of mTOR and exhibits anti-cancer properties. | torin 2 |
Research
Studies (279)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 34 (12.19) | 18.7374 |
1990's | 50 (17.92) | 18.2507 |
2000's | 65 (23.30) | 29.6817 |
2010's | 105 (37.63) | 24.3611 |
2020's | 25 (8.96) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 19 (5.59%) | 5.53% |
Reviews | 7 (2.06%) | 6.00% |
Case Studies | 18 (5.29%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 296 (87.06%) | 84.16% |